Outpatient Treatment for COVID-19.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE
    • Publication Information:
      Original Publication: Chicago : American Medical Association, 1960-
    • Subject Terms:
      Ambulatory Care* ; Antiviral Agents*/therapeutic use ; COVID-19*/therapy ; COVID-19 Drug Treatment*/methods; Humans ; Ritonavir/therapeutic use
    • Grant Information:
      T32 HL007749 United States HL NHLBI NIH HHS
    • Contributed Indexing:
      Local Abstract: [plain-language-summary] This JAMA Patient Page describes current medications available for outpatient treatment of COVID-19 (nirmatrelvir-ritonavir, remdesivir, and molnupiravir), their effectiveness, and how to obtain them.
    • Accession Number:
      0 (Antiviral Agents)
      O3J8G9O825 (Ritonavir)
    • Publication Date:
      Date Created: 20230816 Date Completed: 20240216 Latest Revision: 20240222
    • Publication Date:
      20240222
    • Accession Number:
      10.1001/jama.2023.16666
    • Accession Number:
      37585210